ONE LEVEL DEEPER
ADBE
Warren Buffett frameworkThe Owner-OperatorBenjamin Graham frameworkThe Value ArchitectMichael Mauboussin frameworkThe Expectations EngineerHoward Marks frameworkThe Cycle WhispererPeter Lynch frameworkThe Everyday Edge

When Adobe generates $2.92 billion quarterly FCF at 14x earnings, the pendulum has swung too far.

cautiousBullishconviction

Adobe trades at a 65% discount to peak while generating record profitability — the pendulum has swung from euphoria to despair, creating the asymmetry Marks seeks.

THE LENSES
PRICE VS VALUEdiscounted

Is the price above or below what the business is worth?

DCF fair value of $339.66 vs current price of $243.08 — a 28.4% discount
Reverse DCF implies 0.34% perpetual growth vs trailing FCF growth of 11%
Trading at 14.24x earnings, the 0th percentile of 10-year valuation range
FCF yield of 2.71% at 98th percentile while treasuries yield 4.33%

This framework sees price significantly below intrinsic value. The market implies near-zero growth for a business generating $2.92 billion quarterly free cash flow with 37.8% operating margins. Classic Marks setup — when everyone agrees growth is dead, the price creates opportunity.

Expectations Gap: DCF vs Market
DCF FAIR VALUE
$340
28% discount
MARKET PRICE
$243
Price implies 0.3% growth · Trailing: 11.0%
THE PENDULUMdespair

Where is sentiment — at euphoria or despair?

Stock down 65% from $688 peak, still unrecovered after 1,092 days
Insiders switched from 20 quarters of net selling to net buying at $243
Institutions increased ownership from 78.3% to 81% during the decline
Average double beat generates -4.08% price reaction — no reward for excellence

The pendulum has swung to maximum pessimism. When beating estimates triggers selling and insiders finally turn buyers after 5 years, sentiment has reached the despair that creates opportunity. The pendulum rarely stays at extremes.

Insider Net Buying/Selling
ASYMMETRYfavorable

Does upside significantly exceed downside?

28.4% below DCF fair value with 40% upside to consensus target of $349.65
PE at 0th percentile suggests limited further compression possible
Operating margins at 37.8% and ROIC at 9.8% — both near decade highs
Generating $2.92 billion quarterly FCF provides downside cushion

This framework sees favorable asymmetry — 40% upside to fair value with valuation already at historical floor. The combination of record profitability and minimum valuation creates the skewed risk/reward Marks seeks.

P/E Ratio
CYCLE TEMPERATUREdivergent

Where are we in the cycle?

ROIC improved from 2.8% to 9.8% over 2 years — 98th percentile
Operating margin at 37.8% near all-time highs — 95th percentile
Revenue growth slowed from pandemic peaks to steady 11% rate
Multiple profitability metrics simultaneously at decade highs

Operating metrics suggest late-cycle excellence, but valuation has reset to recession levels. This divergence — peak profitability at trough valuation — suggests the market cycle and business cycle have decoupled, creating opportunity.

ROIC vs Cost of Capital
KEY NUMBERS
VERDICT

Applying this framework reveals a classic Marks setup — the pendulum has swung from euphoria at $688 to despair at $243, creating asymmetric opportunity in a business generating record cash flows. When insiders switch to buying after 20 quarters and the market implies 0.34% growth for a company with proven pricing power, the risk/reward has shifted decisively. Is this the patient capital's moment, when maximum pessimism creates maximum opportunity?

This analysis applies Howard Marks's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Howard Marks. Educational purposes only. Not financial advice.

OTHER PERSPECTIVES
Warren Buffett framework
The Owner-Operator
Bullish
Michael Mauboussin framework
The Expectations Engineer
Bullish
Peter Lynch framework
The Everyday Edge
Bullish
Benjamin Graham framework
The Value Architect
Bullish
Explore
PayPal Holdings, Inc.PYPLWorkday, Inc.WDAYAxon Enterprise, Inc.AXONStarbucks CorporationSBUXExelon CorporationEXCAmgen Inc.AMGN
EDUCATIONAL ONLY · NOT FINANCIAL ADVICEv2